GL1X · GenesisL1 explorer

MolNFT v1 · #123906 · protein

Structure-based tetravalent zanamivir with potent inhibitory activity against drug-resistant influenza viruses

5JYY · Neuraminidase: “Structure-based tetravalent zanamivir with potent inhibitory activity against drug-resistant influenza viruses”. X-ray diffraction, 5 ligands (6PY, MAN, NAG), 1 pocket (best druggability 0.62). MolNFT v1 #123906 on…

PDB
5JYY
Type
protein
Length
388 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Neuraminidase
EC
3.2.1.18
UniProt
R4NFR6
Ligands
6PY, MAN, NAG, BMA, CA
Pockets
1 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANeuraminidase (EC 3.2.1.18)protein3884% helix, 45% strandR4NFR6

Ligands and binding sites

  • 6PY · 5-acetamido-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-7-O-[(2-methoxyethyl)carbamoyl]-D-glycero-D-galacto-non-2-enon ic acid · ligand · chains A
  • MAN · alpha-D-mannopyranose · sugar · 6 copies
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains A
  • BMA · beta-D-mannopyranose · sugar
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12760.620.80436PY

Modifications

Observed in the structure: 9 disulfide, 3 glycan (disulfide, N-glycosylation).

Compared structures

  • 5JYY · Structure-based Tetravalent Zanamivir with Potent Inhibitory Activity against… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.